Liver grafts from selected older donors do not have significantly more ischaemia reperfusion injury

HPB

Volumn 13, Issue 3, 2011, Pages 212-220

  Martins, Paulo N ^a   Chang, Sue ^b   Mahadevapa, Basant ^b   Martins, Ann Britt ^b   Sheiner, Patricia ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

aging; ischaemia reperfusion injury; liver; outcomes; transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; MEPREDNISONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER INJURY; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME;

EID: 79951629882     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2010.00275.x     Document Type: Article

References (57)

1. Scientific Registry of Transplant Recipients. (2005) 2005 Annual Report of the US Organ Procurement and Transplantation Network and Scientific Registry of Transplant Recipients. Transplant data 1995-2004. http://www.ustransplant. org/annual-reports/current/ [Accessed June 2010.
2. Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, et al. (1993) Risk factors for primary dysfunction after liver transplantation-a multivariate analysis. Transplantation 55: 807-813. (Pubitemid 23122053)
3. Berenguer M,. (2008) Risk of extended criteria donors in hepatitis C virus-positive recipients. Liver Transpl 14 (Suppl): 45-50.
4. Strasberg SM, Howard TK, Molmenti EP, Hertl M,. (1994) Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 20: 829-838. (Pubitemid 24296488)
5. Mazzafero V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334: 693-699. (Pubitemid 26079803)
6. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. (2006) Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 6: 783-790. (Pubitemid 43345017)
7. Verbeke P, Fonager J, Clark BF, Rattan SI,. (2001) Heat shock response and ageing: mechanisms and applications. Cell Biol Int 25: 845-857. (Pubitemid 32783458)
8. Lee YK, Manalo D, Liu AK,. (1996) Heat shock response, heat shock transcription factor and cell aging. Biol Signals 5: 180-190.
9. Liu AY, Lee YK, Manalo D, Huang LE,. (1996) Attenuated heat shock transcriptional response in ageing: molecular mechanism and implication in the biology of ageing. EXS 77: 393-408.
10. Cossarizza A, Monti D, Cantini M, Bersani F, Paganelli R, Montagnani G, et al. (1989) Extremely low frequency pulsed electromagnetic fields increase interleukin-2 (IL-2) utilization and IL-2 receptor expression in lymphocytes from old subjects. FEBS Lett 248: 141-144. (Pubitemid 19129331)
11. Globerson A, Effros RB,. (2000) Ageing of lymphocytes and lymphocytes in the aged. Immunol Today 21: 515-521.
12. Okaya T, Blanchard J, Schuster R, Kuboki S, Husted T, Caldwell CC, et al. (2005) Age-dependent responses to hepatic ischaemia/reperfusion injury. Shock 24: 421-427. (Pubitemid 41567353)
13. Park Y, Hirose R, Coatney JL, Ferrell L, Behrends M, Roberts JP, et al. (2007) Ischaemia-reperfusion injury is more severe in older versus young rat livers. J Surg Res 137: 96-102. (Pubitemid 44879438)
14. Detre KM, Lombardero M, Belle S, Beringer K, Breen T, Daily OP, et al. (1995) Influence of donor age on graft survival after liver transplantation- United Network for Organ Sharing Registry. Liver Transpl Surg 1: 311-319.
15. Uemura T, Randall HB, Sanchez EQ, Ikegami T, Narasimhan G, McKenna GJ, et al. (2007) Liver retransplantation for primary non-function: analysis of a 20-year single-centre experience. Liver Transpl 13: 227-233. (Pubitemid 46351648)
16. Buckel E, Sanchez-Urdazpal L, Steers J, Sterioff S, Wiesner R, Krom RA,. (1993) Impaired initial function in liver grafts from donors >50 years of age. Transplant Proc 25: 1558-1559. (Pubitemid 23079100)
17. Alexander JW, Vaughn WK,. (1991) The use of marginal donors for organ transplantation. The influence of donor age on outcome. Transplantation 51: 135-141.
18. Adam R, Sanchez C, Astarcioglu I, Bismuth H,. (1995) Deleterious effect of extended cold ischaemia time on the post-transplant outcome of aged livers. Transplant Proc 27: 1181-1183.
19. Reese PP, Sonawane SB, Thomasson A, Yeh H, Markmann JF,. (2008) Donor age and cold ischaemia interact to produce inferior 90-day liver allograft survival. Transplantation 85: 1737-1744.
20. Tullius SG, Reuzel-Selke A, Ergmann F, Nieminen-Kelha M, Jonas S, Bechstein WO, et al. (2000) Contribution of prolonged ischaemia and donor age to chronic allograft dysfunction. J Am Soc Nephrol 11: 1317-1324. (Pubitemid 30416229)
21. Martins PN, Pratschke J, Pascher A, Fritsche L, Frei U, Neuhaus P, et al. (2005) Age and immune response in organ transplantation. Transplantation 79: 127-132.
22. Martins PN, Chandraker A, Tullius SG,. (2007) Modifying graft immunogenicity and immune response prior to transplantation: potential clinical applications of donor and graft treatment. Transpl Int 19: 351-359.
23. Terasaki PI, Gertson DW, Cecka JM, Cho YW,. (1997) Significance of the donor age effect on kidney transplants. Clin Transplant 11: 366-372. (Pubitemid 27460429)
24. Fausto N, Campbell JS, Riehle KJ,. (2006) Liver regeneration. Hepatology 43 (Suppl): 45-53.
25. Calne RY,. (2000) Immunological tolerance-the liver effect. Immunol Rev 174: 280-282. (Pubitemid 30201395)
26. Popper H,. (1986) Ageing and the liver. Prog Liver Dis 8: 659-683.
27. Woodhouse KW, James OFW,. (1990) Hepatic drug metabolism and ageing. Br Med Bull 46: 22-35. (Pubitemid 20037729)
28. Schnegg M, Lauterburg BH,. (1986) Quantitative liver function in the elderly assessed by galactose elimination capacity, aminopyrine demethylation DH. J Hepatol 3: 164-171. (Pubitemid 17173101)
29. Klotz U, Avant GR, Hoyumpa A, Schenker S, Wilkinson GR,. (1975) The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest 55: 347-359.
30. Rosen HR, Martin P, Goss J, Donovan J, Melinek J, Rudich S, et al. (1998) Significance of early aminotransferase elevation after liver transplantation. Transplantation 65: 68-72. (Pubitemid 28100433)
31. Santori G, Andorno E, Morelli N, Gianelli A, Castiglione A, Casaccia M, et al. (2004) Impact of ischaemia/reperfusion on transplanted livers procured from elderly cadaveric donors. Transplant Proc 36: 2909-2913. (Pubitemid 41126704)
32. Deschênes M, Forbes C, Tchervenkov J, Barkun J, Metrakos P, Tector J, et al. (1999) Use of older donor livers is associated with more extensive ischaemic damage on intraoperative biopsies during liver transplantation. Liver Transpl Surg 5: 357-361. (Pubitemid 29437010)
33. Sakai Y, Zhong R, Garcia B, Wall WJ,. (1993) Tolerance by old livers of prolonged periods of preservation in the rat. Transplantation 55: 18-23. (Pubitemid 23033939)
34. Makowka L, Gordon RD, Todo S, Ohkohci N, Marsh JW, Tzakis AG, et al. (1987) Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant Proc 19: (1 Pt 3): 2378-2382.
35. Greig PD, Woolf H, Sinclair SB, Abecassis M, Strasberg SM, Taylor BR, et al. (1989) Treatment of primary liver graft non-function with prostaglandin E1. Transplantation 48: 447-453. (Pubitemid 19236512)
36. Moore DE, Feurer ID, Speroff T, Gorden DL, Wright JK, Chari RS, et al. (2005) Impact of donor, technical, and recipient risk factors on survival and quality of life after liver transplantation. Arch Surg 140: 273-277. (Pubitemid 41001820)
37. Busuttil RW, Farmer DG, Yersiz H, Hiatt JR, McDiarmid SV, Goldstein LI, et al. (2005) Analysis of longterm outcomes of 3200 liver transplantations over two decades: a single-centre experience. Ann Surg 241: 905-916.
38. Organ Procurement and Transplantation Network (OPTN). (2010) OPTN home page. http://optn.transplant.hrsa.gov/. [Accessed June 2010.
39. Grande L, Matus D, Rimola A, Manyalic M, Cabrer C, García- Valdecasas JC, et al. (1998) Expanded liver donor age over 60 years for hepatic transplantation. Clin Transpl 297-301.
40. Zhao Y, Lo CM, Liu CL, Fan ST,. (2004) Use of elderly donors (60 years) for liver transplantation. Asian J Surg 27: 114-119. (Pubitemid 38619642)
41. Gastaca M, Valdivieso A, Pijoan J, Errazti G, Hernandez M, Gonzalez J, et al. (2005) Donors older than 70 years in liver transplantation. Transplant Proc 37: 3851-3854. (Pubitemid 43015188)
42. Zapletal C, Faust D, Wullstein C, Woeste G, Caspary WF, Golling M, et al. (2005) Does the liver ever age? Results of liver transplantation with donors above 80 years of age. Transplant Proc 37: 1182-1185. (Pubitemid 40590830)
43. Mangus RS, Fridell JA, Vianna RM, Kwo PY, Chestovich P, Milgrom ML, et al. (2009) No difference in clinical transplant outcomes for local and imported liver allografts. Liver Transpl 15: 640-647.
44. Anderson CD, Vachharajani N, Doyle M, Lowell JA, Wellen JR, Shenoy S, et al. (2008) Advanced donor age alone does not affect patient or graft survival after liver transplantation. J Am Coll Surg 207: 847-852.
45. Cescon M, Grazi GL, Cucchetti A, Ravaioli M, Ercolani G, Vivarelli M, et al. (2008) Improving the outcome of liver transplantation with very old donors with updated selection and management criteria. Liver Transpl 14: 672-679. (Pubitemid 351696280)
46. Segev DL, Maley WR, Simpkins CE, Locke JE, Nguyen GC, Montgomery RA, et al. (2007) Minimizing risk associated with elderly liver donors by matching to preferred recipients. Hepatology 46: 1907-1918.
47. Cameron AM, Ghobrial RM, Yersiz H, Farmer DG, Lipshutz GS, Gordon SA, et al. (2006) Optimal utilization of donor grafts with extended criteria: a single-centre experience in over 1000 liver transplants. Ann Surg 243: 748-753. (Pubitemid 44297476)
48. Gruttadauria S, Vizzini G, Biondo D, Mandala L, Volpes R, Palazzo U, et al. (2008) Critical use of extended criteria donor liver grafts in adult-to-adult whole liver transplantation: a single-centre experience. Liver Transpl 14: 220-227. (Pubitemid 351267280)
49. Neipp M, Bektas H, Lueck R, Ceylan D, Becker T, Klempnauer J, et al. (2004) Liver transplantation using organs from donors older than 60 years. Transpl Int 17: 416-423. (Pubitemid 39362569)
50. Hoofnagle JH, Lombardero M, Zetterman RK, Lake J, Porayko M, Everhart J, et al. (1996) Donor age and outcome of liver transplantation. Hepatology 24: 89-96. (Pubitemid 26249418)
51. Brown RS Jr, Lake JR,. (2005) The survival impact of liver transplantation in the MELD era, and the future for organ allocation and distribution. Am J Transplant 5: 203-204. (Pubitemid 40179505)
52. Cassuto JR, Patel SA, Tsoulfas G, Orloff MS, Abt PL,. (2008) The cumulative effects of cold ischaemic time and older donor age on liver graft survival. J Surg Res 148: 38-44.
53. Segev DL, Kucirka LM, Nguyen GC, Cameron AM, Locke JE, Simpkins CE, et al. (2008) Effect modification in liver allografts with prolonged cold ischaemic time. Am J Transplant 8: 658-666. (Pubitemid 351287540)
54. Kemmer N, Secic M, Zacharias V, Kaiser T, Neff GW,. (2007) Longterm analysis of primary non-function in liver transplant recipients. Transpl Proc 39: 1477-1480. (Pubitemid 46907873)
55. Stahl JE, Kreke JE, Malek FA, Schaefer AJ, Vacanti J,. (2008) Consequences of cold ischaemia time on primary non-function and patient and graft survival in liver transplantation: a meta-analysis. PLoS ONE 3: e2468.
56. Tekin K, Imber CJ, Atli M, Gunson BK, Bramhall SR, Mayer D, et al. (2004) A simple scoring system to evaluate the effects of cold ischaemia on marginal liver donors. Transplantation 77: 411-416. (Pubitemid 38209741)
57. Marsman WA, Wiesner RH, Rodriguez L, Batts KP, Porayko MK, Hay JE, et al. (1996) Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 62: 1246-1251. (Pubitemid 27008548)